Clinical trials
Skin Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 3 |
| Completed | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Xiangya Hospital of Central South University | 2 |
| Fujian Longhua Pharmaceutical Co. Ltd | 1 |
| Immorna Biotherapeutics, Inc. | 1 |
| West China Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Skin Neoplasms | 7 |
| Melanoma | 3 |
| Neoplasms | 3 |
| Esophageal Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Skin Diseases | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Adenocarcinoma, Clear Cell | 1 |
| Anus Neoplasms | 1 |
| Basal Cell Carcinoma | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.